Illumina, Inc.

ILMN

$97.78

Name : Illumina, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $15,028,786,176.00

EPSttm : 7.9

Illumina, Inc.

$97.78

1.14%

$1.10

Float Short %

4.91

Margin Of Safety %

-13

Put/Call OI Ratio

0.18

EPS Next Q Diff

-0.02

EPS Last/This Y

12.19

EPS This/Next Y

0.35

Price

97.77

Target Price

110.58

Analyst Recom

2.48

Performance Q

-2.27

Relative Volume

0.68

Beta

1.41

Ticker: ILMN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	ILMN	98.22	0.21	0.49	90175
2025-09-10	ILMN	95.51	0.21	1.00	90503
2025-09-11	ILMN	99.32	0.21	0.30	90915
2025-09-12	ILMN	95.16	0.22	0.65	91301
2025-09-15	ILMN	100.96	0.21	0.68	90118
2025-09-16	ILMN	101.51	0.21	0.88	90798
2025-09-17	ILMN	100.87	0.21308961949711	0.32989690721649	90989
2025-09-18	ILMN	102.99	0.21	0.29	91242
2025-09-22	ILMN	101.48	0.16	0.46	78842
2025-09-23	ILMN	99.33	0.16	1.91	79201
2025-09-24	ILMN	94.4	0.17	0.83	80201
2025-09-25	ILMN	92.23	0.18	0.50	80732
2025-09-26	ILMN	91.44	0.18	0.68	81276
2025-09-29	ILMN	91.89	0.18	0.37	80405
2025-09-30	ILMN	94.99	0.18	0.62	80644
2025-10-01	ILMN	102.29	0.18	0.22	80893
2025-10-02	ILMN	99.25	0.18	0.25	81311
2025-10-03	ILMN	102.08	0.18	0.22	81818
2025-10-06	ILMN	101.02	0.18	0.55	82391
2025-10-07	ILMN	96.67	0.18	1.26	82682
2025-10-08	ILMN	97.79	0.18	0.46	82967
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	ILMN	98.26	2.8	-490.8	4.51
2025-09-10	ILMN	95.53	2.8	-516.9	4.51
2025-09-11	ILMN	99.31	2.8	-454.6	4.51
2025-09-12	ILMN	95.12	2.8	-530.5	4.51
2025-09-15	ILMN	100.96	2.8	-434.8	4.51
2025-09-16	ILMN	101.48	2.8	-486.4	4.51
2025-09-17	ILMN	100.89	2.8	-496.9	4.51
2025-09-18	ILMN	102.99	2.8	-472.0	4.51
2025-09-19	ILMN	102.71	2.8	-494.4	4.51
2025-09-22	ILMN	101.49	2.8	-502.9	4.51
2025-09-23	ILMN	99.37	2.9	-510.9	4.51
2025-09-24	ILMN	94.42	2.9	-537.7	4.51
2025-09-25	ILMN	92.19	2.9	-513.3	4.51
2025-09-26	ILMN	91.69	2.9	-496.5	4.51
2025-09-29	ILMN	91.87	2.9	-489.7	4.51
2025-09-30	ILMN	94.97	2.9	-460.5	4.51
2025-10-01	ILMN	102.28	2.9	-432.8	4.51
2025-10-02	ILMN	99.29	2.9	-529.7	4.51
2025-10-03	ILMN	102.12	2.9	-477.0	4.51
2025-10-06	ILMN	101.03	2.8	-487.1	4.51
2025-10-07	ILMN	96.69	2.8	-542.4	4.50
2025-10-08	ILMN	97.77	2.8	-492.7	4.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	ILMN	0.43	-0.41	5.03
2025-09-10	ILMN	0.43	-0.41	5.03
2025-09-11	ILMN	0.43	-0.41	4.83
2025-09-12	ILMN	0.43	-0.41	4.83
2025-09-15	ILMN	0.43	-0.45	4.83
2025-09-16	ILMN	0.43	-0.45	4.83
2025-09-17	ILMN	0.43	-0.45	4.83
2025-09-18	ILMN	0.43	-0.45	4.83
2025-09-19	ILMN	0.43	-0.45	4.83
2025-09-22	ILMN	0.43	-0.45	4.83
2025-09-23	ILMN	0.43	-0.45	4.83
2025-09-24	ILMN	0.43	-0.45	4.83
2025-09-25	ILMN	0.43	-0.45	4.91
2025-09-26	ILMN	0.43	-0.45	4.91
2025-09-29	ILMN	0.43	-0.44	4.91
2025-09-30	ILMN	0.43	-0.44	4.91
2025-10-01	ILMN	0.43	-0.44	4.91
2025-10-02	ILMN	0.43	-0.44	4.91
2025-10-03	ILMN	0.43	-0.44	4.91
2025-10-06	ILMN	0.43	-0.58	4.91
2025-10-07	ILMN	0.43	-0.58	4.91
2025-10-08	ILMN	0.43	-0.58	4.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.19

Avg. EPS Est. Current Quarter

1.17

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

0.43

Institutional Transactions

-0.58

Beta

1.41

Average Sales Estimate Current Quarter

1064

Average Sales Estimate Next Quarter

1093

Fair Value

85.18

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.9

Max Drawdown 5-Year %

-86.2

Target Price

110.58

P/E

12.38

Forward P/E

20.21

PEG

1.22

P/S

3.51

P/B

6.67

P/Free Cash Flow

14.58

EPS

7.9

Average EPS Est. Cur. Y

4.5

EPS Next Y. (Est.)

4.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.38

Relative Volume

0.68

Return on Equity vs Sector %

30.5

Return on Equity vs Industry %

44.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-492.7

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8970

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y